IP Library Granted Patent US 9,487,779
Granted Patent B2
US 9,487,779 · App. 14/297,378 · Granted Nov 8, 2016

siRNA-mediated gene silencing

Inventors: Beverly L. Davidson (Iowa City, IA); Henry Paulson (Iowa City, IA); Victor Miller (Iowa City, IA); Cynthia Gouvion (Iowa City, IA)
Assignee: University of Iowa Research Foundation
C12N15/113C12N15/111C12N15/1137C12Y302/01031A01K2217/05A61K38/00A61K48/00C12N2310/111C12N2310/14C12N2310/53C12N2330/30C12N2799/021C12N2799/022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,487,779
App. No.
14/297,378
Granted
Nov 8, 2016
Kind
B2
Abstract

The present invention is directed to small interfering RNA molecules (siRNA) targeted against an allele of interest, and methods of using these siRNA molecules.

Claims (26)

1. A mammalian cell comprising

a first strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein the first strand is complementary to at least 15 nucleotides of a mutant Ataxin-3 transcript encoded by siC7 (5′-CTGTCCTGATAGGTCCCGCTGC-3′ SEQ ID NO: 16), siG10 (5′-CTGATAGGTCCCCCTGCTGC-3′ SEQ ID NO:18), siC7/8 (5′-CTGTCCTGATAGGTCCGGCTGC-3′ SEQ ID NO:20), or siC10 (5′-CTGATAGGTCCCGCTGCTGC-3′ SEQ ID NO:22), and wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and

a second strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end,

wherein at least 12 nucleotides of the first and second strands are complementary to each other and form a small interfering RNA (siRNA) duplex under physiological conditions, and wherein the siRNA silences only one allele of the targeted gene in the cell.

2. The cell of claim 1 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure.

3. The cell of claim 2 , wherein the loop structure contains from 4 to 10 nucleotides.

4. An isolated RNA duplex comprising a first strand of RNA having a 5′ end and a 3′ end, and a second strand of RNA, wherein the first strand comprises 22 nucleotides complementary to mutant Ataxin-3 transcript encoded by siC7 (5′-CTGTCCTGATAGGTCCCGCTGC-3′ SEQ ID NO: 16), siG10 (5′-CTGATAGGTCCCCCTGCTGC-3′ SEQ ID NO:18), siC7/8 (5′-CTGTCCTGATAGGTCCGGCTGC-3′ SEQ ID NO:20), or siC10 (5′-CTGATAGGTCCCGCTGCTGC-3′ SEQ ID NO:22), wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and wherein the second strand is complementary to all the nucleotides of the first strand.

5. The RNA duplex of claim 4 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure.

6. The RNA duplex of claim 4 , wherein the loop structure contains from 4 to 10 nucleotides.

7. An expression cassette comprising a nucleic acid encoding at least one strand of the RNA duplex of claim 4 .

8. A vector comprising the expression cassette of claim 7 .

9. A vector comprising two expression cassettes, a first expression cassette comprising a nucleic acid encoding the first strand of the RNA duplex of claim 4 and a second expression cassette comprising a nucleic acid encoding the second strand of the RNA duplex of claim 4 .

10. A cell comprising the expression cassette of claim 7 .

11. An isolated RNA duplex comprising a first strand of RNA having a 5′ end and a 3′ end, and a second strand of RNA, wherein the first strand comprises 22 nucleotides complementary to mutant APP transcript encoded by siT8/C9 (5′-ATTCTGCATCCAGATTCACT-3′ SEQ ID NO: 83), siT9/C10 (5′-TTCTGCATCCAGATTCACTT-3′ SEQ ID NO:85), siT10/C11 (5′-TCTGCATCCAGATTCACTTC-3′ SEQ ID NO:86), siT11/C12 (5′-TGCATCCAGATTCACTTCA-3′ SEQ ID NO:88), or siT12/C13 (5′-TGCATCCAGATTCACTTCAG-3′ SEQ ID NO: 90), wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and wherein the second strand is complementary to all the nucleotides of the first strand.

12. The RNA duplex of claim 11 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure.

13. The RNA duplex of claim 11 , wherein the loop structure contains from 4 to 10 nucleotides.

14. An expression cassette comprising a nucleic acid encoding at least one strand of the RNA duplex of claim 11 .

15. A vector comprising the expression cassette of claim 14 .

16. A vector comprising two expression cassettes, a first expression cassette comprising a nucleic acid encoding the first strand of the RNA duplex of claim 14 and a second expression cassette comprising a nucleic acid encoding the second strand of the RNA duplex of claim 14 .

17. A cell comprising the expression cassette of claim 14 .

18. A mammalian cell comprising

an isolated first strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein the first strand is complementary to at least 15 nucleotides of mutant APP transcript encoded by siT8/C9 (5′-ATTCTGCATCCAGATTCACT-3′ SEQ ID NO: 83), siT9/C10 (5′-TTCTGCATCCAGATTCACTT-3′ SEQ ID NO:85), siT10/C11 (5′-TCTGCATCCAGATTCACTTC-3′ SEQ ID NO:86), siT11/C12 (5′-TGCATCCAGATTCACTTCA-3′ SEQ ID NO:88), or siT12/C13 (5′-TGCATCCAGATTCACTTCAG-3′ SEQ ID NO: 90), and wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and

an isolated second strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end,

wherein at least 12 nucleotides of the first and second strands are complementary to each other and form a small interfering RNA (siRNA) duplex under physiological conditions, and wherein the siRNA silences only one allele of the targeted gene in the cell.

19. The cell of claim 18 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure.

20. The cell of claim 19 , wherein the loop structure contains from 4 to 10 nucleotides.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2016
From: DAVIDSON, BEVERLY L.; PAULSON, HENRY; MILLER, VICTOR; GOUVION, CYNTHIA
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION, INC.
Reel/Frame 039173/0830 →
CONFIRMATORY LICENSE Recorded Jan 21, 2015
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034783/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2014
From: DAVIDSON, BEVERLY L.; PAULSON, HENRY; GOUVION, CYNTHIA
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 033495/0761 →
Continuity (8)
Continuation 13668739 · Nov 5, 2012
Continuation 12952449 · Nov 23, 2010
Continuation 10738642 · Dec 16, 2003
Continuation In Part PCTUS0316887 · May 6, 2003
Continuation In Part 10430351 · May 5, 2003
Continuation 10322086 · Dec 17, 2002
Continuation In Part 10212322 · Aug 5, 2002
Related Publication 20160040159A1 · Feb 11, 2016